VanEck Associates
TNDM icon

VanEck Associates’s Tandem Diabetes Care TNDM Stock Holding History

VanEck Associates’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,918
Closed -$56K – 1479
2026
Q1 		$56K Sell
2,918
-512
-15% -$11.1K ﹤0.01% 1332
2025
Q4 		$75K Buy
3,430
+1,381
+67% +$24.9K ﹤0.01% 1336
2025
Q3 		$25K Sell
2,049
-4,492
-69% -$60.8K ﹤0.01% 1364
2025
Q2 		$122K Sell
6,541
-857
-12% -$17K ﹤0.01% 1291
2025
Q1 		$142K Buy
7,398
+2,497
+51% +$73.1K ﹤0.01% 1253
2024
Q4 		$177K Buy
4,901
+1,074
+28% +$36.3K ﹤0.01% 1239
2024
Q3 		$123K Sell
3,827
-324
-8% -$13.7K ﹤0.01% 1242
2024
Q2 		$167K Sell
4,151
-1,947
-32% -$81.2K ﹤0.01% 1204
2024
Q1 		$216K Buy
6,098
+198
+3% +$5.3K ﹤0.01% 1169
2023
Q4 		$175K Buy
5,900
+467
+9% +$9.69K ﹤0.01% 1179
2023
Q3 		$113K Buy
5,433
+280
+5% +$7.69K ﹤0.01% 1218
2023
Q2 		$126K Buy
5,153
+1,069
+26% +$34.4K ﹤0.01% 1212
2023
Q1 		$166K Sell
4,084
-113
-3% -$4.68K ﹤0.01% 1192
2022
Q4 		$189K Buy
4,197
+3,366
+405% +$152K ﹤0.01% 1112
2022
Q3 		$40K Buy
+831
New +$45.6K ﹤0.01% 1279

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

VanEck Associates's TNDM Position: Q2 2026 in Review

VanEck Associates sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 2,918 shares — an estimated $56K sold.

VanEck Associates first reported a position in TNDM in Q3 2022 and held it in 15 quarters. The position peaked at $216K in Q1 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • VanEck Associates reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • VanEck Associates sold 2,918 Tandem Diabetes Care shares in Q2 2026, an estimated $56K.
  • VanEck Associates first reported a position in Tandem Diabetes Care in Q3 2022 and held it in 15 quarters.
  • VanEck Associates's Tandem Diabetes Care position peaked at $216K in Q1 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.